Literature DB >> 3037683

The influence of ispaghula husk and lactulose on the in vivo and the in vitro production capacity of short-chain fatty acids in humans.

H S Rasmussen, K Holtug, J R Andersen, E Krag, P B Mortensen.   

Abstract

To evaluate factors influencing the short-chain fatty acid (SCFA) concentrations in stools, three different experiments were performed: faecal concentrations of SCFA at defecation were determined by gas liquid chromatography in nine healthy volunteers on a free diet. SCFAs were 114 +/- 15.0 mmol/l (means +/- SD). The coefficient of variation (CV) of the assay was 4-15%, the intraindividual CV 12-33%, and the interindividual CV 11-29%. On incubation of faeces at 37 degrees C concentrations of SCFA doubled in 6 h and rose fourfold in 72 h. In three volunteers the experiments were extended by adding ispaghula husk or lactulose to the diet for two 14-day periods each; no change in faecal SCFA concentrations was seen, either at defecation or after incubation. When ispaghula husk or lactulose was added to faeces in an in vitro incubation system, the concentrations of SCFA were five times higher than those of controls. We conclude that instant handling of faeces is essential for determinations of SCFA concentrations to obtain interpretable and comparable results; that determination of total SCFA output is of limited value; that addition of fibre to the diet does not influence faecal SCFA concentrations; and that the capacity for SCFA production in faeces is large provided a sufficient amount of substrate is available.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037683     DOI: 10.3109/00365528708991482

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Digestibility and bulking effect of ispaghula husks in healthy humans.

Authors:  P Marteau; B Flourié; C Cherbut; J L Corrèze; P Pellier; J Seylaz; J C Rambaud
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

2.  Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans.

Authors:  L El Oufir; B Flourié; S Bruley des Varannes; J L Barry; D Cloarec; F Bornet; J P Galmiche
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

3.  Colonic lactate metabolism and D-lactic acidosis.

Authors:  H Hove; P B Mortensen
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 4.  The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes.

Authors:  Natural Chu; James Ling; He Jie; Kathy Leung; Emily Poon
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.